Bispecific Antibody Therapeutics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

In a single molecule, bispecific antibodies have two antigen-binding sites. Bispecific antibodies appear in a variety of sizes and shapes, ranging from tiny proteins with two associated antigen-binding fragments to massive IgG-like molecules with additional domains. The therapeutic success of currently existing bispecific antibodies has accelerated bispecific antibody development in oncology. According to Globaldata's database, 106 bispecific antibody compounds are in development. 45 of the 106 bispecific antibody medicines in clinical development are aimed mostly at blood cancers, while the rest are aimed at solid tumors, mostly lung and gastrointestinal cancers. https://www.databridgemarketresearch.com/reports/global-bispecific-antibody-therapeutics-market